The Valley Desk

NCT01178073 · Interventional trial

A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)

Overall registry status Completed

Phase 3

Conditions Hypertension, Pulmonary

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov